PROGRAM OVERVIEW
Tune in to this on-demand activity from the NLA’s Clinical Lipid Update in Minneapolis! Test your
knowledge of
uncommon lipid disorders as you diagnose two virtual patients and workshop their cases
along with our experts..
ACTIVITY TYPE
Internet Enduring Activity
FEE FOR PARTICIPATION
No Fee
RELEASE DATE: March 16, 2020
EXPIRATION DATE: March 16, 2021
TARGET AUDIENCE
This activity is designed to meet the needs of lipidologist, internists, endocrinologists, physician
assistants,
pharmacists, registered nurses, nurse practitioners, and advance practice registered nurses with an
interest in
lipid management.
LEARNING OBJECTIVES
At the Conclusion of this activity, participants should be able to:
- Demonstrate knowledge of the mechanisms and manifestations of complex lipid disorders.
- Counsel patients with complex lipid disorders on treatment and/or management plans.
CRITERIA FOR SUCCESS
This activity is designed to be completed within the time designated on the title page; physicians
should claim
only those credits that reflect the time actually spent in the activity. To successfully earn credit,
participants must complete the activity online during the valid credit period that is noted on the title
page.
To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 100% on the
post-test. The
deadline to
claim credit is March 16, 2021.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
COMMERCIAL SUPPORT
This activity is supported by educational funding provided by Alexion.
CREDIT DESIGNATION
CME credit provided
by
the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National
Lipid
Association. The National Lipid Association is jointly accredited by the Accreditation Council for
Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American
Nurses
Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
The National Lipid Association designates this enduring internet activity for a maximum of 1.00 AMA
PRA
Category
1 Credits™. Physicians should claim only credit commensurate with the extent of their
participation in
this
activity.
Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.
Pharmacist Accreditation Statement
Universal Activity Number – JA0007192-0000-20-009-H01-P (Application)
This Activity has been approved for 1.00 contact hour(s) (.10 CEUs) of the Accreditation Council for
Pharmacy
Education.
Nursing
The maximum number of hours awarded for this CE activity is 1.0 contact hours.
Daniel E. Soffer, MD, FNLA
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA
Director of Pediatric Cardiology
Ascension St. John Children's Hospital
Clinical Assistant Professor of Pediatrics
Wayne State University School of Medicine
Detroit, MI
Past- President, National Lipid Association
Clinical Assistant Professor of Medicine
Director, Bellevue Hospital Lipid Clinic
New York, NY
DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or
unapproved by
the FDA. Please refer to the official prescribing information for each product for discussion of
approved
indications, contraindications, and warnings
DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in
all of
its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any
financial
relationships with commercial interests as defined by the ACCME. .
DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in
his/her
practice and professional development and is not to be considered a diagnostic tool to replace
professional
advice or treatment. The course serves as a general guide to the healthcare professional, and therefore,
cannot
be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA
specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from
information in the course, for undetected error, or through reader’s misunderstanding of content.
PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all
copyrighted
materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions
have
also been obtained from identifiable patients in photographs and other images, consistent with the DHHS
HIPAA
regulations for individual privacy.
Name | Relationship | Company |
---|---|---|
Premchand Anne, MD, MPH, MBA | N/A | Nothing to disclose |
Daniel E. Soffer, MD, FNLA |
Advisory Board Contracted Research Speakers Bureau |
Akcea, Amgen, AstraZeneca, Esperion, Ionis Pharmaceuticals, Kowa, Novartis, Sanofi, Regeneron,
Regenex
Sanofi |
James A. Underberg, MD, MS, FNLA |
Advisory Board
Consultant Contracted Research Speakers Bureau |
Amgen, Sanofi, Regeneron, Ambry, Alexion, Akcea, Amarin
Amgen Aegerion, Pfizer Amgen, Amarin, Aegerion, Alexion, Akcea, Sanofi, Regeneron |
Name | Relationship | Company |
---|---|---|
NLA | N/A | NLA staff has nothing to disclose. |
B Bottenberg, DO, FNLA | N/A | Nothing to disclose. |
Casey Elkins, DNP, CLS, FNLA | Speaker | Regeneron/ Sanofi |
This page was last updated: Mar 16, 2020